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MicroarrayFsp27 is a lipid droplet-associated protein almost exclusively expressed in adipocytes where it facilitates
unilocular lipid droplet formation. In mice, Fsp27 deﬁciency is associated with increased basal lipolysis,
browning of white fat and a healthy metabolic proﬁle, whereas energetically challenged Fsp27 deﬁcient mice
(ob/ob/Fsp27−/−) show dramatically reduced fat mass, hepatic steatosis and insulin resistance which represents
a typical lipodystrophy phenotype. Here, we investigate the effect of Fsp27 depletion on the gene expression of
gonadal white adipose tissue (GWAT) under normal or energetically challenged condition (Fsp27−/− vs Wild
type; ob/ob/Fsp27−/− vs ob/ob). We systematically analyzed the change in signaling pathway in Fsp27 deﬁcient
mice. The raw data have been deposited into Gene Expression Omnibus (GEO): GSE59807 and GSE22693.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationrganism/cell line/tissue Mus musculus/gonadal white adipose tissue
ex Male
equencer or array type Microarray
ata format Raw data
xperimental factors ob/obmice and ob/ob/Fsp27−/−mice
xperimental features Microarray gene expression proﬁling to identify
Fsp27 regulated genes
onsent Data are publicly available
mple source location Beijing, ChinaSa1. Direct link to deposited data
The deposited data can be found at: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE59807 and http://www.ncbi.nlm.nih.gov/
sites/GDSbrowser?acc=GDS3768.hua University, Beijing 100084,
Zhou).
. This is an open access article under2. Experimental design, materials and methods
2.1. Mouse handling, RNA isolation and data analysis
ob/ob and ob/ob/Fsp27−/−miceweremaintained in the animal facil-
ity of the Center of Biomedical Analysis at Tsinghua University (Beijing,
China). Four months old mice were used. Total RNA was isolated from
GWAT with TRIzol (Invitrogen). Equal amounts of total RNA from 3
mice were combined to form RNA pools. In total, we analyzed 3 RNA
pools from 9 ob/obmice and 3 RNA pools from 9 ob/ob/Fsp27−/−mice.
First-strand cDNA synthesis was performed using the Superscript
First-Strand Synthesis System (Invitrogen). Six Affymetrix gene chips
(GeneChip Mouse Gene 1.0 ST Array, Affymetrix, USA) were used for
hybridization and data collection. Microarray data related to WT and
Fsp27−/−mice were from Li et al. (GSE22693) [1]. Quality control and
statistical analysis of all the Mouse Gene 1.0 ST microarray data were
conducted using R/Bioconductor. Methods including scatterplots, distri-
bution histograms, boxplots, and unsupervised Principle Component
Analysis (PCA) were employed to visualize the data before and after
preprocessing procedures. All arrays were consistent and comparable
for further analysis, and we performed background adjustment,
quantile normalization and summaries of transcript-level intensity for
all arrays using the Robust Multi-array Average (RMA) algorithm
followed by two rounds of probeset ﬁltering. After removing control
probesets, 28,858 probesets from the original 35,556 were retained.
Next, the detection above background (DABG) p-values for probesetsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
The most signiﬁcant up-regulated and down-regulated pathways in the GWAT
of ob/ob/Fsp27−/−mice were identiﬁed using Wiki pathway analysis.
The total represents the total number of genes in one gene pathway. The
measured represents the number of geneswith altered expression pattern (using
the criteria described above), and the positive represents the number of up-
regulated or down-regulated genes. Z score means the standard statistical test
under the hypergeometric distribution. Green indicates same pathway changed
both in this Supplementary Tables 1 and 2. Yellow indicates speciﬁc changed
pathways when compared with Table 2. LFC means log ratio of fold change.
Up-regulated pathways:
Pathway Positive (r) Measured (n) Total % Z score
Positive (r) Measured (n) Total % Z score
Electron transport chain 91 100 116 91.00% 21.41
Oxidative phosphorylation 52 59 65 88.14% 15.75
TCA cycle 27 31 45 87.10% 11.22
Fatty acid beta oxidation 26 34 46 76.47% 10.02
Fatty acid biosynthesis 16 22 26 72.73% 7.56
Mitochondrial LC-Fatty acid beta-oxidation 13 16 21 81.25% 7.39
Amino acid metabolism 37 92 205 40.22% 6.78
Glycolysis and gluconeogenesis 23 48 70 47.92% 6.37
Triacylglyceride synthesis 13 23 26 56.52% 5.55
Adipogenesis 42 132 134 31.82% 5.43
Heme biosynthesis 6 9 21 66.67% 4.32
Glycogen metabolism 14 34 42 41.18% 4.26
Arachidonate epoxygenase epoxide hydrolase 3 3 13 100.00% 4.1
Nuclear receptors 12 38 38 31.58% 2.84
Cholesterol biosynthesis 6 15 30 40.00% 2.69
Tryptophan metabolism 12 43 48 27.91% 2.35
Diurnally regulated genes with circadian orthologs 13 48 48 27.08% 2.32
One carbon metabolism and related pathways 12 45 86 26.67% 2.17
Kennedy pathway 5 14 29 35.71% 2.15
Oxidative stress 7 23 29 30.43% 2.05
Pentose phosphate pathway 3 7 19 42.86% 2.05
Acetylcholine synthesis 3 7 17 42.86% 2.05
Mitochondrial gene expression 6 19 23 31.58% 2.01
Down-regulated pathways:
Pathway
B cell receptor signaling pathway 61 155 157 39.35% 7.63
Chemokine signaling pathway 63 180 198 35.00% 6.65
IL-5 signaling pathway 30 69 70 43.48% 5.97
IL-3 signaling pathway 37 99 101 37.37% 5.53
Kit receptor signaling pathway 28 67 67 41.79% 5.51
T cell receptor signaling pathway 45 132 134 34.09% 5.38
Focal adhesion 57 184 192 30.98% 5.24
Toll-like receptor signaling pathway 34 94 98 36.17% 5.07
DNA replication 18 41 47 43.90% 4.66
Cell cycle 30 86 90 34.88% 4.52
EGFR1 signaling pathway 49 174 177 28.16% 4.08
G1 to S cell cycle control 22 61 64 36.07% 4.05
IL-4 signaling pathway 21 61 63 34.43% 3.7
Apoptosis 26 83 84 31.33% 3.57
Toll like receptor signaling 13 33 33 39.39% 3.48
Complement and coagulation cascades 20 60 64 33.33% 3.44
G13 signaling pathway 14 38 38 36.84% 3.31
Regulation of actin cytoskeleton 40 150 157 26.67% 3.28
IL-7 signaling pathway 15 44 45 34.09% 3.08
Type II interferon signaling (IFNG) 12 33 36 36.36% 3.01
MAPK signaling pathway 40 157 162 25.48% 2.95
Inflammatory response pathway 11 30 32 36.67% 2.92
Complement activation, classical pathway 7 16 18 43.75% 2.89
Prostaglandin synthesis and regulation 11 31 40 35.48% 2.79
Hypertrophy model 8 20 21 40.00% 2.78
Apoptosis modulation by HSP70 7 17 18 41.18% 2.69
TGF-beta receptor signaling pathway 37 150 152 24.67% 2.61
Endochondral ossification 18 62 67 29.03% 2.59
Matrix metalloproteinases 10 29 30 34.48% 2.55
Small ligand GPCRs 7 18 19 38.89% 2.51
Nucleotide metabolism 7 19 36 36.84% 2.34
Senescence and autophagy 25 98 100 25.51% 2.33
Glucuronidation 5 12 33 41.67% 2.3
IL-2 signaling pathway 20 76 76 26.32% 2.23
Integrin-mediated cell adhesion 24 97 102 24.74% 2.11
IL-1 signaling pathway 11 37 38 29.73% 2.11
Homologous recombination 5 13 13 38.46% 2.09
Androgen receptor signaling pathway 26 109 114 23.85% 1.99
Signaling of hepatocyte growth factor receptor 10 34 34 29.41% 1.97
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(p b 0.05) were considered as “present”. We only retained probesets
ﬂagged as present in at least one sample for each type of tissue, and
used the package LIMMA to identify probesetswhichwere differentially
expressed between the ob/ob/Fsp27−/− and ob/obmice. The Benjamini
and Hochberg method was used to estimate the false discovery rate
(FDR) and correct for multiple hypotheses testing. Annotation was
taken, and genes that changed by log fold of at least 0.5 between
ob/ob/Fsp27−/− and ob/obmice and with a FDR b 0.05 were considered
signiﬁcant. The up- and down-regulated genes were further mapped to
biological pathways using PathVisio with Wiki Pathways content, and
the results were sorted by Z-score, which is the standard statistical
test under the hypergeometric distribution.
3. Results and discussion
3.1. Multilocular LDs in the adipocytes of ob/ob/Fsp27−/−mice
ob/ob/Fsp27−/−mice show reduced fat mass and TAG storage com-
pared with ob/ob mice [2]. The gonadal white adipose tissue (GWAT)
was dramatically reduced compared with ob/obmice. In mature adipo-
cytes, only one large LD per adipocytewas detected in ob/ob adipocytes,
whereas Fsp27 deﬁciency in ob/obmice caused multilocular lipid drop-
lets, about more than 200 LDs per mature adipocyte.
3.2. Altered GWAT pathways in Fsp27 deﬁcient mice
To evaluate the effect of reduced lipid storage and smaller LDs on
gene expression, we checked the gene expression proﬁle in the GWAT
of ob/ob/Fsp27−/− and ob/obmice bymicroarray analysis and compared
their expression proﬁle with that in Fsp27−/− andWTmice. 8000 genes
were changed in the GWAT ob/ob/Fsp27−/−mice compared with ob/ob
mice. We analyzed the gene expression network using Wiki pathway
and observed that 23 of total 162 Wiki pathways were signiﬁcantly
increased, whereas 39 pathways were signiﬁcantly decreased in the
GWAT of ob/ob/Fsp27−/− mice compared with that in ob/ob mice
(Table 1). We reanalysed the microarray data of GWAT in Fsp27−/−
and WT mice [1] (Table 2). 14 of the total 162 pathways were signiﬁ-
cantly increased in the GWAT of mice when comparing with WT mice.
Among the 14 increased pathways, 11 pathways were the same like of
the ob/ob/Fsp27−/−mice. However, among the 22 decreased pathways
in Fsp27−/−mice, only 6 pathways were similar to the ob/ob/Fsp27−/−
mice.
3.3. Up-regulated pathways
Most of the 11 pathways (changed in both Fsp27−/− and ob/ob/
Fsp27−/−mice compared with their partners) are involved in electron
transport chain, oxidative phosphorylation, fatty acid oxidation and
TCA cycle indicating that Fsp27 deﬁciency leads to a more metabolic
active fat tissue [3–4]. We also observed that pathways involved in
fatty acid biosynthesis, triacylglyceride synthesis, adipogenesis and cho-
lesterol biosynthesis were also upregulated in ob/ob/Fsp27−/−mice.
3.4. Down-regulated pathways
Importantly, we observed that gene expression levels in IL-1/2/3/4/
5/7 signaling pathway, B&T cell receptor signaling pathway, chemokine
signaling pathway and inﬂammatory response pathway were all mark-
edly decreased (Table 1) indicating decreased inﬂammatory response
in leptin and Fsp27 double deﬁcient mice. At the same time, we did
not observe a large range of reduced inﬂammatory response in the
Fsp27−/− mice as in the ob/ob/Fsp27−/− mice (Table 2). These data
indicate that the reduced inﬂammatory response was speciﬁc in the
ob/ob/Fsp27−/−mice but not in Fsp27−/−mice when comparing with
their partners.
Table 2
The most signiﬁcant up-regulated and down-regulated pathways in the GWAT of
Fsp27−/− mice were identiﬁed using Wiki pathway analysis.
The total represents the total number of genes in one gene pathway. The measured
represents the number of geneswith altered expression pattern (using the criteria described
above), and the positive represents the number of up-regulated or down-regulated. Z score
means the standard statistical test under the hypergeometric distribution. Green indicates
same pathway changed both in this table and in Table 1.
Up-regulated pathways:
Pathway Positive (r) Measured (n) Total % Z score
Positive (r) Measured (n) Total % Z score
Electron transport chain 64 81 116 79.01% 19.7
Oxidative phosphorylation 37 48 65 77.08% 14.65
TCA cycle 23 27 45 85.19% 12.29
Fatty acid beta oxidation 22 30 46 73.33% 10.88
Mitochondrial LC-fatty acid beta-oxidation 12 15 21 80.00% 8.5
Amino acid metabolism 29 71 205 40.85% 8.06
Glycolysis and gluconeogenesis 19 36 70 52.78% 7.99
Fatty acid biosynthesis 12 20 26 60.00% 6.97
Arachidonate epoxygenase epoxide hydrolase 3 3 13 100.00% 4.89
Tryptophan metabolism 10 28 48 35.71% 4.15
Synthesis and degradation of ketone bodies 2 4 8 50.00% 2.47
Eicosanoid synthesis 4 14 36 28.57% 2.08
Nuclear receptors in lipid metabolism and toxicity 4 15 40 26.67% 1.92
Cholesterol biosynthesis 4 15 30 26.67% 1.92
Down-regulated pathways:
Pathway
Cytoplasmic ribosomal proteins 45 76 82 59.21% 9.56
Complement activation, classical pathway 10 10 18 100.00% 6.8
Complement and coagulation cascades 16 28 64 57.14% 5.46
Focal adhesion 45 128 192 35.16% 5.25
Estrogen metabolism 7 10 29 70.00% 4.32
Inflammatory response pathway 9 16 32 56.25% 4.03
Glucuronidation 7 11 33 63.64% 3.98
Endochondral ossification 16 41 67 39.02% 3.57
Senescence and autophagy 25 76 100 32.89% 3.48
Aflatoxin B1 metabolism 3 4 11 75.00% 2.99
Myometrial relaxation and contraction pathways 29 102 161 28.43% 2.85
Dopminergic neurogenesis 4 7 32 57.14% 2.72
Striated muscle contraction 7 16 45 43.75% 2.72
Prostaglandin synthesis and regulation 9 23 40 39.13% 2.68
Hypertrophy model 6 13 21 46.15% 2.67
Regulation of actin cytoskeleton 25 93 157 26.88% 2.32
SHH, FGF8, Stat3 1 1 6 100.00% 2.15
Glucocorticoid & mineralcorticoid metabolism 1 1 31 100.00% 2.15
Irinotecan pathway 4 9 13 44.44% 2.09
Ptf1a related regulatory pathway 3 6 14 50.00% 2.06
TGF beta signaling pathway 11 36 52 30.56% 2.01
Alpha6-beta4 integrin signaling pathway 14 49 67 28.57% 1.98
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